How is POLR3-related leukodystrophy diagnosed?

Information about diagnosis is currently limited for this condition.

Are there treatments for POLR3-related leukodystrophy?

Information about treatment is currently limited for this condition.

What complications can arise from POLR3-related leukodystrophy?

POLR3-related leukodystrophy can lead to several complications, especially related to movement and balance. As the condition progresses, individuals may experience worsening coordination due to cerebellar involvement. Additionally, dental abnormalities can cause discomfort and affect eating and speaking.

How does POLR3-related leukodystrophy affect daily life?

Living with POLR3-related leukodystrophy can be challenging due to developmental delays and coordination issues. Daily activities may require extra support, especially with tasks that involve fine motor skills or balance. Families may need to adapt their home environment and routines to help manage these challenges.

What is the prognosis for someone with POLR3-related leukodystrophy?

Currently, information about the long-term prognosis for POLR3-related leukodystrophy is limited. The condition can lead to progressive symptoms, which may affect quality of life. Ongoing medical care and support can help manage symptoms and improve daily functioning.

Are there any specific specialists I should consult for POLR3-related leukodystrophy?

For POLR3-related leukodystrophy, it is important to work with a team of specialists. This may include neurologists for neurological symptoms, dentists for dental issues, and endocrinologists for hormonal concerns. A multidisciplinary approach can help address the various aspects of the condition.

Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

POLR3-related leukodystrophy - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

POLR3-related leukodystrophy

MONDO:0700282

Find Clinical TrialsTrials

Overview

Hypomyelinating leukodystrophy disorder in which is caused of the disease is a variation in any of the genes encoding POLR3 (RNA polymerase III) subunits, including POLR3A, POLR3B and POLR1C. This disorder is characterized by the association of dental abnormalities (delayed dentition, abnormal order of dentition, hypodontia), hypogonadotropic hypogonadism, and hypomyelinating leukodystrophy manifesting with neurodevelopmental delay or regression and/or progressive cerebellar symptoms.

OnsetCHILDHOOD, JUVENILE

Clinical Trials1 registered · 1 recruiting

Clinical Presentation

Built from Human Phenotype Ontology (HPO) phenotype annotations and GeneReviews clinical descriptions. Features represent findings documented across known cases — not an exhaustive list of possible symptoms.

No HPO annotations are available for this condition.

Age of onset: childhood, adolescence.

GeneReviews

Clinical Guidance

POLR3-related leukodystrophy is a hypomyelinating leukodystrophy characterized by neurologic (cerebellar, extrapyramidal, pyramidal, and cognitive) and non-neurologic (dental, endocrine, and ocular) features. Before the identification of the involved genes, five overlapping clinical phenotypes were described and are now all recognized as part of the spectrum of POLR3-related leukodystrophy:

Diagnosis

Drawn from GeneReviews diagnostic guidelines, newborn screening panel status (RUSP), and ClinGen gene-disease validity classifications. Reflects current clinical evidence and consensus where available.

GeneReviews

Diagnostic Criteria

Suggestive Findings

POLR3-related leukodystrophy should be suspected in individuals with the following major/shared clinical features, which may or may not be present:

Neurologic dysfunction: progressive cerebellar features, including:
Gait ataxia, dysarthria, dysmetria, tremor, eye movement abnormalities; and
To a lesser extent, extrapyramidal (typically dystonia), pyramidal, and cognitive features

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for POLR3-related leukodystrophy. The disease remains an area of unmet medical need.

GeneReviews

Management Guidelines

Evaluations Following Initial Diagnosis

To establish the extent of disease and needs of an individual diagnosed with a POLR3-related leukodystrophy, the following are recommended:

Pediatric neurology consultation

Prognosis

GeneReviews

Surveillance Guidelines

No general surveillance guidelines have been developed to date; monitoring should be individualized.

Source: GeneReviews — "POLR3-Related Leukodystrophy"

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.

12 publications have been identified in PubMed for POLR3-related leukodystrophy. Research spans Case Report / Case Series (42%), Epidemiology / Natural History (25%), and Diagnostic / Biomarker (8%).

Research Type	Count	% of Total
Patient case studies	5	42%

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 1 active clinical trial a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

FAQ

Frequently Asked Questions

Common questions about POLR3-related leukodystrophy

POLR3-related leukodystrophy is a type of hypomyelinating leukodystrophy disorder. It is caused by variations in genes that encode subunits of RNA polymerase III, such as POLR3A, POLR3B, and POLR1C. This condition affects the formation of healthy myelin in the nervous system, which is important for proper nerve communication. People with this condition may experience a range of symptoms, including dental abnormalities, such as delayed dentition, abnormal tooth order, or missing teeth, as well as issues related to hormone production. The disorder often presents with neurodevelopmental delays or regression and may include progressive symptoms that affect movement and balance due to cerebellar involvement.

Common signs of POLR3-related leukodystrophy include dental problems like delayed or abnormal dentition, reduced number of teeth (hypodontia), and potential hormonal issues such as hypogonadotropic hypogonadism. Neurological symptoms may include developmental delays, regression in skills, and progressive problems with coordination due to cerebellar dysfunction.

The condition is caused by genetic variations in the genes that encode subunits of RNA polymerase III, specifically POLR3A, POLR3B, and POLR1C. These genetic changes affect how myelin is produced in the nervous system and contribute to the other features of this disorder. Associated genes include POLR3A, POLR3B, POLR1C, POLR3K.

← Back to All Diseases

Kisho

POLR3-related leukodystrophy

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Treatment

Management Guidelines

Evaluations Following Initial Diagnosis

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Differential Diagnosis

PLP1 disorders

Treatment of Manifestations

Clinical Guidance

Therapies Under Investigation

Clinical Trials

Recent Publications

POLR3-related leukodystrophy

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Treatment

Management Guidelines

Evaluations Following Initial Diagnosis

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is POLR3-related leukodystrophy?

What are the symptoms of POLR3-related leukodystrophy?

What causes POLR3-related leukodystrophy?

How is POLR3-related leukodystrophy diagnosed?

Are there treatments for POLR3-related leukodystrophy?

What complications can arise from POLR3-related leukodystrophy?

How does POLR3-related leukodystrophy affect daily life?

What is the prognosis for someone with POLR3-related leukodystrophy?

Are there any specific specialists I should consult for POLR3-related leukodystrophy?

Differential Diagnosis

PLP1 disorders

Treatment of Manifestations

Clinical Guidance

Therapies Under Investigation

Clinical Trials

Recent Publications